Drug Shortage Report for EMLA CREAM

Last updated on 2024-01-18 History
Report ID 209402
Drug Identification Number 00886858
Brand name EMLA CREAM
Common or Proper name lidocaine 2.5% and prilocaine 2.5% 5g Tube with 2 Tegaderm dressings
Company Name ASPEN PHARMACARE CANADA INC.
Market Status MARKETED
Active Ingredient(s) LIDOCAINE PRILOCAINE
Strength(s) 2.5% 2.5%
Dosage form(s) CREAM
Route of administration TOPICAL TOPICAL
Packaging size 1 Tube
ATC code D04AB
ATC description ANTIPRURITICS,INCL ANTIHIST,ANESTHET,ETC.
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2023-12-15
Actual start date 2023-12-20
Estimated end date 2024-01-15
Actual end date 2024-01-08
Shortage status Resolved
Updated date 2024-01-18
Company comments VR44798CA1 / CAD2EM012B1 EMLA 25MG:25MG/G CRE TB 1X5G CA ASP
Health Canada comments
Tier 3 Status No
Contact Address UNIT 8, 1155 NORTH SERVICE ROAD WEST
OAKVILLE, ONTARIO
CANADA L6M 3E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2024-01-18 French Compare
v15 2024-01-18 English Compare
v14 2024-01-04 French Compare
v13 2024-01-04 English Compare
v12 2023-12-21 English Compare
v11 2023-12-19 French Compare
v10 2023-12-19 English Compare
v9 2023-12-16 English Compare
v8 2023-12-12 French Compare
v7 2023-12-12 English Compare
v6 2023-12-12 English Compare
v5 2023-12-02 English Compare
v4 2023-12-01 French Compare
v3 2023-12-01 English Compare
v2 2023-11-06 French Compare
v1 2023-11-06 English Compare

Showing 1 to 16 of 16